Skip to main content
Equibles
SPOK logo

SPOK · Spok Holdings, Inc · Metrics

Track SPOK — free

Use SPOK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPOK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.76 +0.01 (+0.09%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$246.14M
Shares
20.93M
Volume · Nov 6 205.24K Avg daily vol (3M) 163.23K

SPOK metrics

115 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.76
Market cap
$246.14M

Price action

23 metrics
Price change (1W)
-1.9%
Price change (30D)
+6.3%
Price change (3M)
+2.1%
Price change (6M)
+8.0%
Price change (YTD)
-10.8%
Price change (1Y)
-11.5%
Trailing year
Price change (5Y)
+11.5%
52-week high
$13.94
52-week low
$10.11
Change from 52-week high
-15.6%
Change from 52-week low
+16.3%
Annualized volatility
31.6%
Annualized volatility (3M)
39.8%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.1
RSI (14D)
62.8
Price vs SMA 50
+9.1%
Price vs SMA 200
+4.7%
Avg volume (3M)
163,227
Relative volume
1.3
Average dollar volume
$1.78M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
20.93M

Valuation

12 metrics
P / E (TTM)
13.4
Trailing earnings · reciprocal yield 7.5%
PEG ratio
0.1
EV / revenue
1.6×
reciprocal yield 62.5%
EV / EBITDA
10.2×
reciprocal yield 9.8%
EV / EBIT
12.4×
reciprocal yield 8.1%
P / sales
1.8×
reciprocal yield 54.9%
P / book
1.7
reciprocal yield 58.7%
FCF yield
12.2%
TTM · current market cap
Buyback yield
0.0%
P / FCF
8.2
reciprocal yield 12.2%
P / operating cash flow
7.4
reciprocal yield 13.6%
Earnings yield
7.6%

Historical valuation

8 metrics
P / E historical average (3Y)
19.3×
reciprocal yield 5.2%
P / E historical average (5Y)
16.5×
reciprocal yield 6.1%
EV / revenue historical average (3Y)
2.0×
reciprocal yield 51.0%
EV / revenue historical average (5Y)
1.6×
reciprocal yield 62.1%
EV / EBIT historical average (3Y)
14.1×
reciprocal yield 7.1%
EV / EBIT historical average (5Y)
51.2×
reciprocal yield 2.0%
EV / EBITDA historical average (3Y)
11.7×
reciprocal yield 8.5%
EV / EBITDA historical average (5Y)
13.3×
reciprocal yield 7.5%

Dividends & buybacks

7 metrics
Dividend yield
10.6%
Trailing 12 months
Payout ratio
146.2%
Shareholder yield
—
Dividend / share (TTM)
$1.25
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-19

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
78.6%
Operating margin
12.9%
Trailing 12 months
Net margin
13.9%
Gross profit (TTM)
$106.16M
Operating profit (TTM)
$17.45M
Net income (TTM)
$18.75M
Trailing 12 months
Diluted EPS (TTM)
$0.88
FCF margin
22.3%
Effective tax rate
27.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$6.34
Gross profit per diluted share (TTM)
$4.98
Operating profit per diluted share (TTM)
$0.82
EBITDA per diluted share (TTM)
$1.00
Net income per diluted share (TTM)
$0.88
Operating cash flow per diluted share (TTM)
$1.56
Free cash flow per diluted share (TTM)
$1.41
Capital expenditures per diluted share (TTM)
$0.16
R&D per diluted share (TTM)
$0.61
Stock compensation per diluted share (TTM)
$0.28
Book value per share
$7.10

Growth

11 metrics
Revenue growth YoY
-2.6%
Year over year
Net income growth YoY
+203.4%
Revenue (TTM)
$135.10M
Trailing 12 months
EPS growth YoY
+206.7%
Shares change YoY
+0.9%
Year over year · more shares
Revenue CAGR (3Y)
+1.3%
Revenue CAGR (5Y)
-1.2%
EPS CAGR (3Y)
-11.7%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+111.1%
FCF CAGR (5Y)
+2.1%

Quality

14 metrics
Return on equity
13.0%
Return on assets
9.5%
Debt / equity
0.0
Current ratio
1.3
EBITDA (TTM)
$21.18M
Free cash flow (TTM)
$30.07M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
-1.4
Return on invested capital
11.1%
Trailing 12 months
Net cash
$30.07M
Latest balance sheet
Cash & equivalents
$30.07M
Total assets
$198.32M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$33.43M
Capital expenditures (TTM)
$3.35M
R&D (TTM)
$12.99M
SG&A (TTM)
—
Stock compensation (TTM)
$5.95M
R&D / revenue
9.6%
Stock compensation / revenue
4.4%

Ownership (13F)

9 metrics
13F filers
133
13F filer change QoQ
-6
Institutional ownership
52.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
20.0%
Private-fund adviser ownership
19.2%
Active holders' share change QoQ
+2.6%
Holder tenure
14.4
Price vs estimated holder cost
-25.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.1%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 5.3 days to cover
Days to cover
5.3d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$515,517
Insider-sentiment score
20 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1289945 CUSIP 84863T106 13F (30d) 49 filings 37 filers Visit website Investor relations